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The 25 kDa Mad2 protein is a key player in the
spindle assembly checkpoint, a safeguard
against chromosome segregation errors in mi-
tosis. Mad2 combines three unusual properties.
First, Mad2 adopts two conformations with
distinct topologies, open (O) and closed (C)
Mad2. Second, C-Mad2 forms topological links
with its two best-characterized protein ligands,
Mad1 and Cdc20. Third, O-Mad2 and C-Mad2
engage in a ‘‘conformational’’ dimer that is
essential for spindle checkpoint function in
different organisms. The crystal structure of
the O-Mad2–C-Mad2 conformational dimer, re-
ported here, reveals an asymmetric interface
that explains the selective dimerization of the
O-Mad2 and C-Mad2 conformers. The structure
also identifies several buried hydrophobic
residues whose rearrangement correlates with
the Mad2 topological change. The structure of
the O-Mad2–C-Mad2 conformational dimer is
consistent with a catalytic model in which a
C-Mad2 template facilitates the binding of
O-Mad2 to Cdc20, the target of Mad2 in the spin-
dle checkpoint.
INTRODUCTION
The Mad2 protein is conserved in all eukaryotes (Musac-
chio and Salmon, 2007; Taylor et al., 2004). Duringmitosis,
Mad2 and several other spindle assembly checkpoint
(SAC) proteins are recruited to kinetochores, proteina-
ceous chromosomal scaffolds devoted to the capture of
spindle microtubules (Cleveland et al., 2003; Musacchio
and Salmon, 2007; Taylor et al., 2004). At kinetochores,
the SAC proteins monitor the formation of stable kineto-
chore-microtubule attachments (the kinetochore fibers,
or K-fibers), which are required for chromosome congres-730 Cell 131, 730–743, November 16, 2007 ª2007 Elsevier Inc.sion and alignment at the metaphase plate and in the sub-
sequent separation of the sister chromatids at anaphase
(Maiato et al., 2004).
The SAC targets Cdc20, an activator of the Anaphase
Promoting Complex or Cyclosome (APC/C) (Peters,
2006). The Ubiquitin ligase activity of the APC/C is re-
quired to trigger anaphase and mitotic exit. By targeting
Cdc20, the SAC keeps the APC/C in check and prevents
its activation until all sister chromatid pairs are properly
aligned at the metaphase plate (Peters, 2006). This con-
dition satisfies the SAC, whose signal subsides, leading
to APC/C activation and, after a cascade of molecular
events, to the irreversible removal of sister chromatid
cohesion (Peters, 2006).
Mad2 binds directly to Cdc20 and this interaction is es-
sential for SAC function (Hwang et al., 1998; Kim et al.,
1998; Luo et al., 2000; Sironi et al., 2001). The mechanism
whereby Mad2 binds Cdc20 has been intensely investi-
gated (Nasmyth, 2005). The 200-residue sequence of
Mad2 folds as a HORMA domain (Aravind and Koonin,
1998). The HORMA domain of Mad2 adopts two distinct
conformations. A conformation known as C-Mad2 is
observed when Mad2 is bound to Cdc20 (Luo et al.,
2002; Sironi et al., 2002). This binding mode, which will
be described in more detail later on, entails a topological
connection in which the Mad2-binding site of Cdc20 is
held in a binding pocket of Mad2 by a mobile element
known as the ‘‘safety belt’’ (Luo et al., 2002; Sironi et al.,
2002). Kinetochores devoid of microtubules retain a tight
complex of Mad2 with another SAC protein named Mad1
(Chen et al., 1999, 1998; Chung and Chen, 2002; De An-
toni et al., 2005a; Luo et al., 2002; Martin-Lluesma et al.,
2002; Nasmyth, 2005; Sironi et al., 2002; Vink et al.,
2006). The way in which Mad1 binds Mad2 is equivalent
to that of Cdc20, in that Mad1 binds to the same ligand-
binding site of C-Mad2. There is now substantial evidence
that the tight Mad1–Mad2 complex, which is further stabi-
lized by 2:2 tetramerization, does not significantly dissoci-
ate during checkpoint activation (De Antoni et al., 2005a;
Shah et al., 2004; Vink et al., 2006). Its function at the
kinetochore is to recruit from themitotic cytosol a different
conformer of Mad2, known as O-Mad2 (or N1 Mad2), for
Cdc20 binding (De Antoni et al., 2005a; Vink et al., 2006).
The structure of O-Mad2 has also been characterized.
Relative to its position in C-Mad2, the ‘‘safety belt’’ of O-
Mad2 occupies a resting position at the opposite end of
an exposed b sheet ofMad2 (Luo et al., 2000, 2004). Kinet-
ochore recruitment of cytosolic O-Mad2 entails its dimer-
ization with the C-Mad2 moiety of the Mad1–Mad2
complex (De Antoni et al., 2005a, 2005b). The exact signif-
icance of the O-Mad2–C-Mad2 dimerization is unclear
(Nasmyth, 2005), but it seems plausible that after docking
onto C-Mad2, the O-Mad2 conformer bound to C-Mad2
undergoes a conformational change into an ‘‘active’’
form that can bind more readily to Cdc20. Like Mad2,
also Cdc20 is enriched at kinetochores, where it binds to
an unknown receptor (Kallio et al., 1998). The logic of
this network is that the conformational dimerization of O-
Mad2 with Mad1-bound C-Mad2 facilitates the complex
conformational rearrangement required to bind Cdc20,
possibly through the creation of a structural intermediate
(Figure S1 in the Supplemental Data available with this
article online). This model is named ‘‘Mad2 template’’
model, as it suggests that C-Mad2 bound to Mad1 acts
as a template to generate C-Mad2 bound to Cdc20 (De
Antoni et al., 2005a; Nasmyth, 2005; Yu, 2006).
Additional negative and positive regulators, including
p31comet, UbcH10, and USP44, have been recently identi-
fied and shown to be important for regulating the stability
of the Mad2–Cdc20 complex (Habu et al., 2002; Mapelli
et al., 2006; Reddy et al., 2007; Stegmeier et al., 2007;
Xia et al., 2004). Like O-Mad2, p31comet binds specifically
and with high-affinity to C-Mad2, and competes with the
association of O-Mad2 to C-Mad2 (Mapelli et al., 2006;
Vink et al., 2006; Xia et al., 2004). Thus, the ability of
p31comet to negatively regulate the SAC might be based
on its ability to interfere with the interaction of O-Mad2
with C-Mad2. So far, the structural bases of this property
of p31comet have not been clarified.
The structure of the core element of the ‘‘Mad2 tem-
plate’’ model, the O-Mad2–C-Mad2 dimer, has not been
described previously. Here, we report the crystal structure
of the O-Mad2–C-Mad2 complex and discuss its proper-
ties and implications for the SAC. In an accompanying
paper in this issue of Cell, Luo, Yu, and coworkers report
the structure of p31comet bound to C-Mad2 (Yang et al.,
2007). They find that p31comet is structurally related to
Mad2, and that its complex with C-Mad2 bears striking
similarities with the structure of the O-Mad2-C-Mad2
dimer. Together, these structures provide a framework
to understand the implications of Mad2 dimerization in
the SAC and describe what is probably an unprecedented
mechanism for protein dimerization. To harmonize the
description of Mad2 conformers in this paper and in
Yang et al. (2007), the name open-Mad2 (abbreviated as
O-Mad2) will be used to describe structures previously
described as O-Mad2 or N1-Mad2. The name closed-
Mad2 (abbreviated as C-Mad2) will be used to describe
structures previously referred to as C-Mad2, N2-Mad2
and N20-Mad2 (Luo et al., 2000, 2002, 2004; MusacchioCand Salmon, 2007; Sironi et al., 2002; Yu, 2006).
N2-Mad2 has been used to describe an ‘‘empty’’ C-
Mad2 conformer devoid of Mad2 ligands (Luo et al.,
2004; Yu, 2006). We will refer to the ‘‘empty’’ form of C-
Mad2 as ‘‘unliganded C-Mad2.’’ We also propose to
name the hypothetical active form of Mad2, previously of-
ten indicated as Mad2), as intermediate-Mad2 (I-Mad2).
RESULTS AND DISCUSSION
Architecture of the O-Mad2–C-Mad2
Conformational Dimer
Our previous attempts to crystallize the O-Mad2–C-Mad2
complex were unsuccessful, possibly because the inter-
action is highly dynamic (Mapelli et al., 2006; Vink et al.,
2006). To overcome this problem,we tried to create a ‘‘sta-
bilized’’ form of O-Mad2. For this, we deleted residues
109–117 from the loop that connects strand b5 to helix
aC (the b5-aC loop) of human Mad2 and substituted
them with a Gly-Ser-Gly triplet (the resulting mutant is
named Mad2LL, for loop-less. The reason why this mutant
is stabilized as O-Mad2 is explained below). To generate
C-Mad2, we ‘‘closed’’ full-length wild-typeMad2 (Mad2wt)
with Mad2-binding peptide 1 (MBP1), a 12-residue
peptide (sequence Ser-Trp-Tyr-Ser-Tyr-Pro-Pro-Pro-Gln-
Arg-Ala-Val) mimicking the consensus Mad2-binding
motifs of Mad1 and Cdc20 (Luo et al., 2002). In isolation,
Mad2LL and the Mad2wt–MBP1 complex eluted from
a size-exclusion chromatography (SEC) column between
the 44-kDa and 17-kDa markers, i.e., as monomers
(Figure 1A; note that the 12-residue MBP1 peptide does
not contribute significantly to the elution of C-Mad2–
MBP1). A stoichiometric combination of Mad2LL and
Mad2wt–MBP1 generated aMad2LL–Mad2wt–MBP1 com-
plex eluting near the 44 kDa marker (Figure 1A). In the
Mad2wt–MBP1 complex, MBP1 is embedded as an addi-
tional element of the secondary structure of C-Mad2 (see
below). Therefore, we will often refer to the Mad2wt–MBP1
dimer simply as C-Mad2, and to its complex with O-Mad2
as a dimer (rather then a trimer).
We crystallized Mad2LL–Mad2wt–MBP1 and collected
X-ray diffraction data to 2.9 A˚ resolution. The structure
was determined by Molecular Replacement as described
in Experimental Procedures. The model, which has been
refined to a free R-factor of 27.4%, displays good geomet-
rical parameters (Table 1). The structure confirms that
Mad2LL and Mad2wt–MBP1 form an O-Mad2–C-Mad2
conformational dimer (Figures 1B–1D). The topological dif-
ferences between the O-Mad2 and C-Mad2 conformers in
the dimer reside in the N- and C-terminal regions. In
O-Mad2 (Mad2LL), the first part of the N-terminal 15-resi-
due segment is disordered, and the second part forms
the short b1-strand (Figure 1B). This is positioned in a shal-
low cleft between the b5-strand and the aC helix (Figures
1C–1E). Relative to the b1-strand, the b7-b8 hairpin at
the C terminus of Mad2 (red) occupies the opposite end
of the exposed b sheet of O-Mad2, away from the interface
with C-Mad2. In the C-Mad2 protomer, the N-terminalell 131, 730–743, November 16, 2007 ª2007 Elsevier Inc. 731
732 Cell 131, 730–743, November 16, 2007 ª2007 Elsevier Inc.
segment extends the aA helix and forms an additional
short helix (aN, Figure 1B). The C-terminal tail of C-Mad2
(the safety belt, containing the two strands b80-b800), rather
than the b1-strand, occupies the cleft between the b5-
strand and the aC helix. In this new position, obtained by
traversing the entire exposed b sheet of C-Mad2, the
Table 1. Data Collection and Refinement Statistics
Data Collection MBP1–Mad2wt–Mad2LL
Space group P212121
Beamline/Synchroton ID14-2/ESRF
Wavelength (A˚) 0.933
Unit cell dimensions (A˚)
112.58
111.31
131.76
Resolution (A˚)a 30.0  2.9 (3.0  2.9)
Total observations 597,084
Unique reflections 37,591
Data completeness (%) 100.0 (100.0)
Rsym (%)b 11.6 (45.1)
I/sI 16.2 (4.4)
Refinement
Resolution range (A˚) 30.0  2.9
Rconvc/Rfreed 23.4/27.4
Number of protein atoms 9642
Number of solvent atoms 6
Rmsd bond lengths (A˚) 0.018
Rmsd bond angles () 2.0
Mean B-factor protein (A˚2) 39.3
a Values in parentheses refer to the outer resolution shell.
b Rsymm =
Pj I < I > j/P I, where I is the observed intensity of
a reflection and < I > is the average intensity obtained from
multiple observations of symmetry-related reflections.
c Rconv =
P jjFoj  jFcjj/
P jFoj, where Fo and Fc are the ob-
served and calculated structure factor amplitudes respec-
tively.
d Rfree is equivalent to Rconv for a 5% subset of reflections not
used in the refinement.Csafety belt is at the interface with O-Mad2, to which it con-
tributes several contacts. At the opposite edge of the ex-
posed b sheet of C-Mad2, the MBP1 peptide augments
the b sheet after pairing with the b6-strand, and becomes
partially buried under the Mad2 safety belt, as described
previously (Luo et al., 2002; Sironi et al., 2002). The topo-
logical link of MBP1 with C-Mad2 is already evident in
Figure 1F, which shows that theMBP1 chain (green) is em-
braced by the safety belt. The Mad2-binding segments of
Mad1 and Cdc20, which bind to the same pocket of Mad2
(Luo et al., 2002; Sironi et al., 2002), are flanked on either
side by hundreds of residues (Figure S1). This explains
why the association with, and dissociation from, Mad2 of
these ligands implies the opening of the safety belt (Sironi
et al., 2002).
The dimerization of O-Mad2 and C-Mad2–MBP1 re-
ported here is structurally compatible with the binding of
O-Mad2 to the Mad1–C-Mad2 complex (Sironi et al.,
2002). If we superimpose the C-Mad2 moiety of the
O-Mad2–C-Mad2 dimer on the C-Mad2 moiety of the
Mad1–C-Mad2 complex (PDB ID code 1GO4), O-Mad2
nicely fits on the Mad1–C-Mad2 complex without steric
clashes with Mad1 (Figure S1), in agreement with previous
biochemical analyses demonstrating a physical interac-
tion between O-Mad2 and the Mad1–C-Mad2 complex
(De Antoni et al., 2005a).
The Dimer Interface
The structure of the O-Mad2–C-Mad2 conformational
dimer reveals that the interaction surface is asymmetric,
rather than pseudo-symmetric as previously proposed
based on modeling (Mapelli et al., 2006). The interaction
buries a total of 1960 A˚2. Several residues at the
O-Mad2–C-Mad2 interface, including Arg133, Gln134,
Thr140, Phe141 and Arg184, are evolutionarily invariant
or well conserved (Figure 1B). Single alanine mutants of
these residues in Saccharomyces cerevisiae are unable
to sustain the SAC in aMAD2-deficient strain, supporting
the proposition that the function of Mad2 dimerization in
the SAC is conserved in evolution (Mapelli et al., 2006;
Nezi et al., 2006). With an asymmetric interaction surface,
equivalent residues of O-Mad2 and C-Mad2 face different
chemical environments. For instance, Arg133C-Mad2
forms a hydrogen bond with the backbone oxygen
of Gln34O-Mad2, while the side chain of Arg133O-Mad2
stacks against the aromatic ring of Phe141C-Mad2.Figure 1. Structure of the O-Mad2–C-Mad2 Dimer
(A) Mad2LL (red trace) and Mad2wt–MBP1 12-residue peptide complex (green trace) elute between the 44 kDa and 17 kDa markers from a Superdex-
75 SEC column. When combined stoichiometrically, these proteins form a ternary complex that elutes with the 44-kDa marker. The content of
fourteen 300-ml fractions between 9 and 13.2 ml was analyzed by SDS-PAGE and Coomassie staining.
(B) Sequence and secondary structure of O-Mad2 and C-Mad2. Mad2 residues are colored according to the conservation bar shown at the bottom of
the panel, which was calculated based on an alignment of 15 sequences (Mapelli et al., 2006). The circles mark C-Mad2 and O-Mad2 residues at the
dimer interface, respectively, and their color code refers to the location of the contact on the cognate Mad2.
(C and D) Ribbon models of the Mad2 conformational dimer viewed at the indicated rotations.
(E) Topology diagram of O-Mad2 and C-Mad2. In C-Mad2, the two strands b80–b800 are extensions in opposite directions of the b8 strand of O-Mad2,
which justifies the nomenclature b80–b800 for these strands.
(F) Surface models of O-Mad2 and C-Mad2, oriented as in panel (D), have been parted to show the concavity and convexity of the binding surfaces.
Figures were made with Pymol (http://www.pymol.org) and Adobe Illustrator.ell 131, 730–743, November 16, 2007 ª2007 Elsevier Inc. 733
Figure 2. Analysis of the Asymmetric Dimer Interface
(A–D) Enlarged views of the dimer interface roughly corresponding to the boxes on the dimer shown in the upper left and upper right part of the figure.
Panels (A), (C), (B), and (D) are related by 90 rotations. Color-coding for all carbon atoms is as in Figure 1; nitrogen, blue; oxygen, red. Hydrogen
bonds are dashed purple lines.734 Cell 131, 730–743, November 16, 2007 ª2007 Elsevier Inc.
Phe141O-Mad2, on the other hand, is not engaged in in-
teractions with C-Mad2 (Figures 2A–2D). Gln134C-Mad2
is hydrogen-bonded to the side chain of Thr140O-Mad2
and to the carbonyl group of Thr136O-Mad2. Conversely,
Gln134O-Mad2 points away from the interaction surface,
while Thr140C-Mad2 forms a polar interaction with
Thr52O-Mad2 that anchors the b hairpin of O-Mad2
to the aC helix of C-Mad2. The b80-b800 hairpin of
C-Mad2 interacts with O-Mad2 via Arg184C-Mad2, which
is hydrogen-bonded to the carbonyls of Val139O-Mad2
and Leu142O-Mad2, and via a stacking interaction of
Tyr199C-Mad2 with Arg133O-Mad2 (Figures 2A–2D). In O-Mad2,
Arg184 is far from the surface that contacts C-Mad2
(Figure 2E).
With an asymmetric interaction surface, certain resi-
dues are only required for binding on one of the two con-
formers. For instance, the structure predicts that the side
chains of Phe141 and Arg184 are required for the interac-
tion of C-Mad2 with O-Mad2, but should be dispensable
for the interaction of O-Mad2 with C-Mad2. To test this,
we carried out a binding assay that detects the binding
of Mad2 to the Mad2-binding motif of human Cdc20
(Cdc20111–138) and that also discriminates the effects of
mutations on the ability of O- and C-Mad2 to form dimers
(De Antoni et al., 2005a; Mapelli et al., 2006) (Figure 2F).
Consistently with the structure of the O-Mad2–C-Mad2
complex, C-Mad2 versions of the single alanine point
mutants of residues Phe141 or Arg184 (Figure 2F, lanes
5 and 6) prevented the binding of Mad2DC, a deletion mu-
tant lacking 10 residues from the Mad2 C terminus, and
that, like Mad2LL, is a ‘‘locked’’ O-Mad2 conformer (Luo
et al., 2000; Sironi et al., 2002). The same mutations in
O-Mad2 did not significantly alter the binding to C-Mad2wt
(lanes 8 and 9). The effects of mutating Arg184 demon-
strate that the C-terminal region of C-Mad2 is essential
for conformational dimerization. In agreement with our
analysis, we have previously shown that alanine mutants
of Arg133 weaken binding both on the O-Mad2 and on
the C-Mad2 surface (De Antoni et al., 2005b). Like
Arg133, also Thr140 is engaged - in different chemical en-
vironments – in the binding interface of both conformers.
Point mutants of this residue effectively impaired dimer-
ization both in the context of O-Mad2 and of C-Mad2
(lanes 1, 2, 4, and 7). Altogether, these results are fully
consistent with the revelation from the crystal structure
that the O-Mad2–C-Mad2 interface is intrinsically asym-
metric. As the structure-based mutational analysis in
Figure 2F was carried out with O-Mad2DC, whose b5-aCloop is intact, we believe that the observed position of
the aC helix is not significantly affected by the deletion
of the b5-aC loop in Mad2LL.
Topology of the Mad2 Conversion
The structures of O-Mad2 and C-Mad2 suggest that dis-
placement of the b1-strand is a prerequisite for relocating
the b7-b8-harpin of O-Mad2 across the b sheet to create
C-Mad2 (Figure 3A). In C-Mad2, the 1–15 segment (con-
taining b1) appears as an extension of the aA helix. This
rearrangement requires that the 1–15 segment be with-
drawn beneath the b5-aC loop (Figure 3A). A tighter loop
could lock O-Mad2 and prevent the transition. Indeed, the
Mad2LL mutant, which has a shortened b5-aC loop, stably
adopts theO-Mad2 conformation. LikeMad2DC, Mad2LL is
unable to bind Cdc20 (Figure 3B, lanes 2 and 3) or Mad1
(data not shownand ref. Sironi et al., 2001). Thus, the length
of the b5-aC loop of Mad2 is important for relocating the
N-terminal segment of Mad2, which is in turn required for
relocating theC-terminal ‘‘safetybelt’’ (Figure3A).Asstable
O-Mad2 conformers, Mad2DC and Mad2LL bind C-Mad2
normally (Figure 3B, lanes 6 and 7), in agreement with the
observation that neither the C-terminal region of O-Mad2
nor the b5-aC loop ofO-Mad2, are engaged in dimerization
(Figure 1). Thus, Mad2LL and Mad2DC are both stabilized
as O-Mad2 but are both endowed with a fully functional
O-Mad2 interface for C-Mad2binding, which is at the basis
of the dominant-negative effects ofMad2DC (Canmanet al.,
2002). So far,wehaveonlybeenable to crystallizea confor-
mational dimer containing Mad2LL, possibly because
the deletion of the b5-aC loop restricts the mobility of the
N-terminal region in Mad2LL.
In agreement with the idea that Mad2 closure might be
facilitated in the absence of b1, Mad2DN15, a Mad2mutant
lacking the first 15 residues of Mad2, has been proposed
to exist predominantly as a C-Mad2 conformer, even in
the absence of ligands such as Mad1 or Cdc20 (Mapelli
et al., 2006). This form of unliganded C-Mad2, first
described by Yu and colleagues (Luo et al., 2004), is char-
acterized by a closed position of the safety belt despite the
fact that the Mad2 ligand-binding site is devoid of Mad2
ligands (Luo et al., 2004). To confirm that Mad2DN15 folds
as unliganded C-Mad2, we took advantage of the previ-
ous observation that theO-Mad2 andC-Mad2 conformers
can be discriminated based on their profile of elution from
an anion exchange (AE) column (Luo et al., 2004). In agree-
ment with these previous studies, all known O-Mad2 mu-
tants show the same profile of elution from a Resource-Q(E) Surface view of a broken dimer colored as in Figure 1 with ‘‘asymmetric’’ residues shown in black.
(F) GST-Cdc20111–138 on GSH beads was incubated with the Mad2 species labeled in black on the upper part of the panel. After a 1 hr incubation, the
excess Mad2 was washed out and the Mad2 species labeled in red were added for a second 1 hr incubation. After a washing step, SDS-PAGE and
Coomassie staining were used to visualize bound species. Mad2R133E-Q134A (lane 1) is a control Mad2 that binds Cdc20 but is impaired in its inter-
action with O-Mad2 (De Antoni et al., 2005a). The samemutations in the frame of O-Mad2 prevent binding to wild-type C-Mad2 (lane 2). Mad2DC acts
as a ‘‘wild type’’ form of O-Mad2, and binds to the GST-Cdc20111–138–Mad2 complex (lane 3). C-Mad2mutants T140E, F141A and R184A do not bind
Mad2DC (lanes 4–6). O-Mad2 mutant T140E failed to bind C-Mad2wt (lane 7). The O-Mad2 F141A and R184A mutations did not prevent O-Mad2 from
binding C-Mad2wt (lanes 8 and 9) demonstrating that they act asymmetrically on the opposing surfaces. The protein samples used in these exper-
iments are also shown.Cell 131, 730–743, November 16, 2007 ª2007 Elsevier Inc. 735
Figure 3. Topology of the Mad2 Conver-
sion
(A0–A00 0) Schematic view of the Mad2 closure
showing selected elements of the secondary
structure. In (A0), the N-terminal (blue) and
C-terminal (red) regions of O-Mad2 are still in
place. The conversion in (A00) requires that the
N-terminal b1-strand is removed to allow the
relocation of the C-terminal region. Eventually,
the N-terminal region needs to relocate at the
N-terminus of Mad2, and the passage requires
an ‘‘opening’’ through the b5-aC loop. C-Mad2
is schematized in (A00 0).
(B) The Cdc20-binding and dimerization prop-
erties of different ‘‘topological’’ mutants of
Mad2 were tested in the same binding assay
already introduced in Figure 2, panel F. Mad2wt
binds GST-Cdc20111–138 (lane 1) but the con-
stitutively locked O-Mad2 forms Mad2DC and
Mad2LL do not (lanes 2 and 3). Mad2DN15 and
Mad2DN15-LL bind GST-Cdc20111–138, indicat-
ing that they can adopt a closed Mad2
conformation (lanes 4 and 5). Like Mad2DC
and Mad2LL (lanes 6 and 7), Mad2DN15 and
Mad2DN15-LL can also adopt the O-Mad2
conformation to bind bind C-Mad2wt (lanes 6
and 7).
(C) Anion exchange chromatography sepa-
rates monomeric O-Mad2 from C-Mad2 (see
also Figure S2). Different Mad2 mutants with
similar isoelectric points (Table S1) elute in a
‘‘conformation-sensitive’’ way from an anion-
exchange column. Mad2wt, Mad2DC, Mad2LL,
and Mad2V193N eluted as O-Mad2 species.
Mad2DN15, Mad2DN15-LL, Mad2L13A and
Mad2L13Q elute as C-Mad2. Eluted fractions
were collected and analyzed by SDS-PAGE.AE column (Figure 3C and data not shown). Conversely,
Mad2DN15 elutes at higher salt concentrations, in agree-
ment with the idea that this mutant folds preferentially as
unliganded C-Mad2. Indeed, we have shown previously
that Mad2DN15 dimerizes with O-Mad2, as expected for
a protomer in the closed conformation (Mapelli et al.,
2006). The conditions for the validity of the AE assay are
described in more detail in the Experimental Procedures
section, in the legend of Figure S2, and in Table S1.
In summary, our data show that in the absence of the
first fifteen N-terminal residues, Mad2 (Mad2DN15) prefers
an unliganded C-Mad2 conformation, but this preference
does not imply that unliganded C-Mad2 is the more stable
conformer of the intact protein. Indeed, Mad2wt eluted as
an O-Mad2 conformer under the conditions of our assay
(Figure 3C). Loss of the N-terminal region is likely to affect
the stability of the Mad2 hydrophobic core, as explained
below. Mad2DN15 also retained the ability to bind GST-
Cdc20111–138 (Figure 3B, lane 4). Although the re-opening
of the C-terminal tail is slow (Luo et al., 2004), this obser-
vation is consistent with the time scale of our binding
experiments (1 hr at 20C).
If the deletion of the b5-aC loop restricts the mobility
of the N-terminal region in Mad2LL, generating a barrier736 Cell 131, 730–743, November 16, 2007 ª2007 Elsevier Inc.to Mad2 closure, one would predict that the deletion
of the Mad2 N-terminal region from Mad2LL should sup-
press the inability to reposition the b7-b8 hairpin to form
C-Mad2. To test this, we created the double deletion
mutant Mad2DN15-LL. Consistent with our prediction,
Mad2DN15-LL prefers the C-Mad2 conformation (Fig-
ure 3C). Like Mad2DN15, Mad2DN15-LL also binds to
Cdc20111–138 (Figure 3B, lane 5). Once bound to GST-
Cdc20111–138, Mad2DN15 (data not shown) and
Mad2DN15-LL behave essentially as wild-type C-Mad2
species in terms of O-Mad2 binding (Figure 3B, lane 10),
in agreement with the fact that the N-terminal segment
of C-Mad2 is not involved at the dimer interface (Fig-
ure 1B). Although these results do not clarify the exact
order of modifications required to create C-Mad2 from
O-Mad2, they indicate that the removal of the N-terminal
region of Mad2 from the position it occupies in O-Mad2
and its relocation through the b5-aC loop are prerequisite
to forming C-Mad2.
Conversion of the Mad2 Core
The substitution of the b1 strand of O-Mad2 with the
b80-b800 hairpin of C-Mad2 involves a modification of the
Mad2 hydrophobic core (Figures 4A–4C). In O-Mad2,
Cthe side chain of Leu13 (in b1) inserts between the side
chains of Phe23 and Phe24 of the aA helix (Figure 4A). Dis-
placement of Leu13 from this site in C-Mad2 correlates
with rotation of the side chains of Phe23 and Phe24
(Figure 4B). In C-Mad2, these side chains are in van der
Waals contact with the side chains of Phe186 and
Val193 in the b80-b800 hairpin (Figure 4B). To test the con-
tribution of Leu13 to the stability of O-Mad2, we mutated
it to Ala (Mad2L13A) or to Gln (Mad2L13Q) and analyzed
the conformation of the resulting mutants. Strikingly,
Mad2L13A andMad2L13Q preferred the C-Mad2 conforma-
tion, recapitulating the effects of the ‘‘topological’’ mutants
Mad2DN15 and Mad2DN15-LL (Figure 3C). Like Mad2DN15
and Mad2DN15-LL, Mad2L13A and Mad2L13Q retained the
ability to bind GST-Cdc20111–138 (Figure 4D and data not
shown). On the opposite front, Val193 is expected to
play a prominent role in stabilizing C-Mad2, because its
aliphatic side chain is exposed to solvent in O-Mad2 but
is buried in the hydrophobic core of C-Mad2 (Figure 4B).
Accordingly, mutation of Val193 into the polar residue
Asn (Mad2V193N) generates a mutant that is locked as
O-Mad2 (Figure 3C), and is totally defective in Cdc20
binding (Figure 4D).
The O-Mad2–C-Mad2 and p31comet–C-Mad2
Dimers Compared
The structure of the p31comet–C-Mad2 dimer (Yang et al.,
2007) reveals striking similarities with the structure of the
O-Mad2–C-Mad2 dimer (Figures 5A and 5B). As de-
scribed more thoroughly in the accompanying paper by
Yang et al. (2007), p31comet structurally resembles Mad2,
and it binds to an area of the C-Mad2 surface that largely
overlaps with that bound by O-Mad2. As p31comet acts as
a negative regulator of the SAC, the structure immediately
suggests that p31comet is likely to act by direct competition
with the interaction of O-Mad2with C-Mad2, as previously
proposed (De Antoni et al., 2005a; Habu et al., 2002;
Mapelli et al., 2006; Vink et al., 2006; Xia et al., 2004).
Besides the overall similarity, significant differences in
the two dimeric structures provide possible clues to
understand the structural conversion of Mad2. After su-
perposition of the (essentially identical) C-Mad2 moieties
of the two complexes, it appears that p31comet covers
a slightly larger area of the C-Mad2 surface relative to
Figure 4. Hydrophobic Core of Mad2 in the Conversion
(A) Hydrophobic core of O-Mad2.
(B) Hydrophobic core of C-Mad2.
(C) Superposition of hydrophobic cores of O-Mad2 andC-Mad2 show-
ing differences in the choice of rotamers.
(D) The Cdc20-binding and dimerization properties of different ‘‘topo-
logical’’ mutants of Mad2 were tested in the same binding assay al-
ready introduced in Figure 2F. Mad2L13Q and Mad2V193N (lanes 2 and
3) mimic Mad2DN15 and Mad2DC, respectively, in their ability (or lack
thereof) to bind GST-Cdc20111–138, indicating that L13 and V193 play
prominent functions for the stabilization of the O-Mad2 and C-Mad2
topologies.ell 131, 730–743, November 16, 2007 ª2007 Elsevier Inc. 737
Figure 5. The p31comet–C-Mad2 Complex and Its Relationship with O-Mad2–C-Mad2
(A) The O-Mad2–C-Mad2 complex is viewed as in Figure 1C.
(B) Ribbon diagram of the p31comet–C-Mad2 complex (Yang et al., 2007). p31comet is colored green. The orientation is the same as in (A).
(C) Close-up of the hydrophobic core of Mad2, showing the central position of Trp100 near the aC helix. The side chain of Phe141 points toward
solvent.
(D) Tyr165 of p31comet (equivalent to Trp100 of Mad2) is in very close contact with the side chain of Phe200, which is buried in p31comet hydrophobic
core. It is possible that the burial of Phe200 stabilizes a specific conformation of the hydrophobic core of p31comet that contributes to its stronger
binding to C-Mad2.
(E) Mutating Trp100 of Mad2 to Tyr (W100Y) generates a stable O-Mad2 mutant that binds to GST-Cdc20111–138 with very slow kinetics.O-Mad2 and that it fits more snugly to the C-Mad2 surface
(see Figure 6B of Yang et al. [2007]). This correlates with
a higher affinity of the interaction of p31comet with C-738 Cell 131, 730–743, November 16, 2007 ª2007 Elsevier IncMad2 relative to O-Mad2 (Mapelli et al., 2006; Vink et al.,
2006). In more detail, there is good structural overlap
between p31comet and O-Mad2 around the aC helices,.
Figure 6. Superposition of O-Mad2 and
C-Mad2
(A) On the left hand side, C-Mad2O-Mad2 and
O-Mad2 are superimposed and colored as in
Figure 1. C-Mad2 is colored dark gray, and
the MBP1 peptide (green). The segments
used for the superposition are described in
Experimental Procedures. The red arrowheads
indicate points of steric clash between the
O-Mad2-superimposedC-Mad2 in a hypothet-
ical C-Mad2–C-Mad2 dimer.
(B) The view is 90 away from (A).
(C) Superposition of the independent views of
C-Mad2 derived from the crystal structure of
the conformational dimer described here and
the structure of isolated C-Mad2 (i.e., not
bound to O-Mad2) in the Mad1–C-Mad2 core
complex (PDB ID Code 1GO4; [Sironi et al.,
2002]) confirmed that C-Mad2 is a rigid scaf-
fold, whose hydrophobic core remains essen-
tially invariant even in the choice of side chain
rotamers upon O-Mad2 binding (not shown).Cell 131, 730–743, November 16, 2007 ª2007 Elsevier Inc. 739
suggesting that docking of the aC helices is essential for
tight C-Mad2 binding (Yang et al., 2007). On the other
hand, the aA helix of p31comet and the following aAB helix
(which is equivalent to the b2-b3 hairpin) make extensive
contacts with C-Mad2 that are not observed for the equiv-
alent elements of the O-Mad2–C-Mad2 interaction.
NMR chemical shift perturbation experiments revealed
that O-Mad2 undergoes a global conformational change
when incubated with C-Mad2 (Mapelli et al., 2006). Such
change is consistent with the idea that C-Mad2 operates
on O-Mad2 to create a conformational intermediate,
I-Mad2, which might be expected to bind more readily
to Cdc20. Indeed, the extensive conformational change
that separates O-Mad2 from C-Mad2 is expected to imply
significant activation energies, i.e., to be slow. This
hypothesis found a first experimental confirmation (Luo
et al., 2004). We have now confirmed that the forward
rate constant (kon) for the association of Mad2 with
Cdc20 in the absence of Mad2 dimerization is 3–4 orders
of magnitude slower that those that are normally observed
for protein-protein interactions (M. Simonetta, R.Manzoni,
M.M., L.M., S.S., A.M., and A. Ciliberto, unpublished
data).
Within the framework defined in the previous para-
graph, it is plausible that the deletion of the b5-aC loop
in Mad2LL locks O-Mad2 in a form that cannot undergo
further change. Thus, we suspect that our structure
provides a snapshot of the initial docking of O-Mad2
onto C-Mad2. We speculate that part of the binding en-
ergy from conformational dimerization of O-Mad2 with
C-Mad2might be used to trigger a conformational change
in the Mad2 core required to convert the Mad2 topology.
In this respect, the structure of the p31comet–C-Mad2
complex might reveal certain aspects of the I-Mad2
intermediate. For instance, evident differences between
p31comet and O-Mad2 are that the aA and aC helices
have a different reciprocal orientation, and that the aC
helix of p31comet is significantly shorter than the equivalent
helix of O-Mad2 (Figures 5A and 5B). These changes cor-
relate with the burial of Phe200 into the hydrophobic core
of p31comet (Figure 5D). The latter residue is equivalent to
Phe141 of O-Mad2, which is fully exposed and is impor-
tant for C-Mad2 binding to O-Mad2 (Figures 2 and 5D).
It is possible that besides playing a role at the surface of
C-Mad2, Phe141 of Mad2 represents a possible site of
‘‘communication’’ with the core of Mad2 that might be
important for the stabilization of I-Mad2. In p31comet,
Phe200 is in van der Waals contact with Tyr165. The
equivalent residue in Mad2 is Trp100, which is fully con-
served in the Mad2 subfamily of HORMA domains. To
test if this residue is important for the structural transition
of Mad2, we mutated it into tyrosine (Mad2W100Y).
Mad2W100Y is a very stable mutant that folds as O-Mad2
(Figure S3). We then tested the ability of Mad2W100Y to
bind Cdc20111–138. In agreement with our hypothesis
that Trp100 is important for the structural conversion of
Mad2, Mad2W100Y binds Cdc20 to levels that are compa-
rable to those of wild-type Mad2, but the reaction has740 Cell 131, 730–743, November 16, 2007 ª2007 Elsevier Inc.extremely slow kinetics, reaching equilibrium only after
48–72 hr (Figure 5E and data not shown). While an in-
depth structural analysis will be required to understand
the behavior of Mad2W100Y, our results suggest that the
hydrophobic core of Mad2 is an essential element of the
Mad2 conformational change. Several other residues
have different rotamers in the O-Mad2 and C-Mad2 hy-
drophobic core and define a possible chain starting at
the aC helix and ending near the Mad2 C-terminal region
(Figure 4C). In normal conditions (i.e., with wild-type
O-Mad2), the docking of aCO-Mad2-helix might have reper-
cussions on the side chain of several hydrophobic resi-
dues in the vicinity of Leu13, such as Phe23, Ile128, and
Ile135 favoring the extrusion of Leu13 from its position
in the O-Mad2 core and accelerating the rate-limiting
release of the b1-strand. In turn, this might correlate with
rotations of other side chains, including those of Phe24,
Ile28, and Phe151, to facilitate extrusion of the C-terminal
tail (Figure 4C). A full analysis of this still speculative model
of structural change in theMad2 core will be the subject of
our future studies.
Determinants of Asymmetric Binding
The binding pattern revealed by the O-Mad2–C-Mad2 and
p31comet–C-Mad2 complexes likely explains why O-Mad2
dimers are not observed (De Antoni et al., 2005a, 2005b;
Nezi et al., 2006). Most likely, the inability to form O-Mad2
dimers is due to the fact that at least one C-terminal tail
(from C-Mad2) is required at the dimer interface (Figure 1).
Indeed, mutation of R184 prevents C-Mad2 from binding
O-Mad2 (Figure 3F).
The observation that p31comet has a topology that re-
sembles C-Mad2 (Yang et al., 2007) might suggest that
asymmetric C-Mad2 dimers similar to O-Mad2–C-Mad2
are possible. But rather than from the topology itself, the
likelihood of an asymmetric dimerization of two C-Mad2
protomers should be evaluated on the quality of the fitting
of the actual structures. We built a model of a C-Mad2–C-
Mad2 dimer by superimposing the crystallographic model
of C-Mad2 on O-Mad2 in the O-Mad2–C-Mad2 dimer.
As O-Mad2 and p31comet superimpose well on the aC
helix (Figure S4 and data not shown), we modeled
C-Mad2O-Mad2 (the superscript indicates that this is the
subunit superimposed on O-Mad2) based on the fitting
of the aC helix. The model suggests that C-Mad2O-Mad2
cannot be rigidly accommodated at the interface with
C-Mad2–MBP1 due to steric clash between the b2-b3
hairpin and the aC helix of C-Mad2, and between the aA
helix of C-Mad2O-Mad2 and the aC helix of C-Mad2 at
residue Gln134 (Figure 6B). These considerations suggest
that asymmetric C-Mad2–C-Mad2 dimers similar to
O-Mad2–C-Mad2 or to p31comet–C-Mad2 are unlikely to
form. It remains formally possible, however, that the bind-
ing interface can be molded to allow the formation of
C-Mad2 dimers (Luo et al., 2004; Yu, 2006). Further
biochemical and structural analyses will be required to
shed light on this issue.
CONCLUSIONS
The Mad2 protein is endowed with an astonishing collec-
tion of unusual properties. Crystal structure determination
of the Mad1–Mad2 complex revealed a safety belt binding
mechanism and was instrumental for developing the
‘‘Mad2 template’’ model (Figure S1) (De Antoni et al.,
2005a; Sironi et al., 2002). Strong evidence in favor of
this model so far is that the stoichiometry and dynamics
of the interaction of Mad2 with kinetochores can be faith-
fully reproduced with a purified system containing a stable
Mad1–C-Mad2 complex (the kinetochore receptor) and
O-Mad2 (the cytosolic component) (De Antoni et al.,
2005a; Shah et al., 2004; Vink et al., 2006). This result
indicates that conformational dimerization of Mad2 takes
place at kinetochores. The structure of the Mad2 confor-
mational dimer described here provides the first detailed
view of the mechanism of binding of O-Mad2 to
C-Mad2. The asymmetry of the Mad2 dimer is its most
striking property, not only in the conformations of the
two polypeptide chains but also in the chemical environ-
ment at the binding interface. Small deviations from
2-fold symmetry occur frequently at the interface of other-
wise symmetric dimers (Brown, 2006). Fully asymmetric
dimers, on the other hand, are rare. In the recently discov-
ered example of the intracellular domain of the Epidermal
Growth Factor Receptor (EGFR), an asymmetric dimer
forms transiently upon EGF stimulation to activate the in-
tracellular kinase domain (Zhang et al., 2006). The two
EGFR subunits are probably chemically and conforma-
tionally identical and are therefore expected to have an
equal chance to occupy either side of the asymmetric
dimer. Certain aspects of Mad2 dimerization are reminis-
cent of the interaction of themajor histocompatibility com-
plex class II (MHC II) molecules with the peptide-editing
factor DM. DM is structurally related to MHC II and acts
on MHC II to catalyze the exchange of peptides in the
peptide-binding groove of MHC II (Busch et al., 2005).
But the asymmetric conformational dimer of Mad2 is
probably unprecedented in the protein world, as in this
case the interaction involves two structurally distinct
Mad2 moieties endowed with the same sequence, and
one of which folds stably as C-Mad2 after associating
with Mad1 or Cdc20. Topological differences in the fold
of the same protein are very rare. A notable example is
that of the Serpins, whose latent and active states are
characterized by the insertion or removal of a b strand in
the middle of a b sheet (Whisstock and Bottomley,
2006). Future studies will have to address the idea that
the C-Mad2moiety acts as a catalyst to promote themod-
ification of O-Mad2 into I-Mad2 required to bind Cdc20.
The confirmation of this hypothesis poses very important
technical challenges. The static structure of the Mad2
conformational dimer shown here cannot provide a defini-
tive answer to this hypothesis, but is consistent with it. By
identifying distinct changes in theMad2 hydrophobic core
that are required to support the Mad2 conformational
change, and surface residues involved in dimerization,Cthe structure illuminates the path for future experiments
aimed to dissecting this problem.
EXPERIMENTAL PROCEDURES
Protein Biochemistry
Full-length HsMad2 and Mad2LL were expressed with an N-terminal
hexahistidine-tag from pET43 (Novagen) at 16C in E. coli strain
BL21-pLysS (DE3) for 12 hr after induction with 0.1 mM IPTG. Cells
were lysed by sonication in 50 mM Tris-HCl (pH 8), 0.3 M NaCl, 5%
glycerol, 5 mM imidazole and Roche Complete EDTA-free protease in-
hibitor cocktail. After clearing, the lysate was loaded on a HiTrap metal
chelating column (GE Healthcare). Bound proteins were eluted with an
imidazole gradient. Mad2 containing fractions were pooled, desalted,
and loaded onto an anion-exchange (AE) Resource-Q column (GE
Healthcare) equilibrated in 10 mM Tris-HCl (pH 8.0), 30 mM NaCl,
5% glycerol, 0.5 mM EDTA and 1 mM DTT. The protein was eluted
using a NaCl gradient, concentrated by ultrafiltration, and further sep-
arated by size exclusion chromatography (SEC) on a Superdex-75 col-
umn (GEHealthcare) equilibrated in 10mMTris-HCl (pH 8), 0.1MNaCl,
5% glycerol, 0.5 mM EDTA and 1 mM DTT. The entire purification
scheme was carried out at 4C.
Deletion of residues 109–117 was achieved by PCR amplification of
the whole pET43 vector containing the Mad2 gene with the following
phosphorylated primers: forward 50-GGATCCGGAGAAAAGTCTCAG
AAAGCTATCCAG, reverse 30-CTTGTCACACTCAATATCAAACTG. Af-
ter PCR, themethylated template was cleavedwith the DpnI restriction
enzyme. The PCR product was ligated and used to transform TOP10
competent cells (Invitrogen).
To assemble the O-Mad2–C-Mad2 dimer, synthetic MPB1 peptide
was incubated with purified full-lengthMad2wt in a 5-fold molar excess
for 1 hr at 20C. A slight excess Mad2LL was subsequently added and
the incubation prolonged for an additional hour. The O-Mad2–C-Mad2
dimer was separated on a Superdex-75 (GE Healthcare) sizing column
pre-equilibrated in 10 mM Tris-HCl (pH 8) and 0.1 M NaCl. Analytical
SEC analyses were performed on a Superdex-75 column in a SEC
buffer consisting of 20 mM Tris-HCl (pH 7.6), 0.1 M NaCl, 0.5 mM
EDTA and 1 mM DTT. Analytical AE chromatography was carried out
on a Resource-Q column on which pure proteins were loaded in
20 mM Tris-HCl (pH 7.6), 30 mM NaCl, 0.5 mM EDTA and 1 mM
DTT, and eluted with a linear salt gradient up to 0.4 M in 15 column
volumes at 4C. Point mutations were introduced with QuikChange
(Stratagene). C- and N- terminal deletion mutants were generated as
previously described (Mapelli et al., 2006). All constructs were verified
by sequencing.
Crystallization and Crystal Structure Determination
Crystallization experiments were performed with the sitting drop vapor
diffusion technique at 20C. 100 nl of protein solution at 43mg/ml were
mixedwith 100 nl of reservoir solutionwith aCartesian Honeybee liquid
handler (Genomic Solutions). Crystals grew with a reservoir containing
0.1 M NaAcetate (pH 4.6) and 3.5 M NaFormate (SALTRX screen,
HamptonResearch).Crystalswere flash-cooled in liquidN2without fur-
ther optimization or cryo-protection. X-ray diffraction data were col-
lected at beamline ID14-2 at ESRF (Grenoble, France). Data were in-
dexed and scaled with HKL2000 (Otwinowski and Minor, 1997).
Molecular Replacement (MR) was carried out with PHASER (McCoy
et al., 2004) using the Mad2 chain of the Mad1–Mad2 crystallographic
complex as a search model (PDB entry 1GO4). MR only located the
threecopiesofC-Mad2,whichwere relatedbyaproper 3-fold noncrys-
tallographic symmetry axis. The 3-fold symmetrywas subsequently ex-
ploited in DM (Collaborative Computational Project, 1994) for density
modification. The 3-fold symmetry axis runs exactly through a Nickel
atom coordinating the well-ordered His-tags of the C-Mad2 subunits.
Model building of the open conformers was initiated with helical frag-
ments placed into the modified electron density by the HelixBuildell 131, 730–743, November 16, 2007 ª2007 Elsevier Inc. 741
module of ArpWarp (Morris et al., 2002). The model was then com-
pleted using iterative cycles of manual model building in Coot (Emsley
and Cowtan, 2004) and restrained refinement in CNS (Brunger et al.,
1998). Tight initial noncrystallographic symmetry restraints were re-
laxed at the end of the refinement. The three O-Mad2–C-Mad2 copies
in the asymmetric unit are identical except for part of the C-terminal re-
gion of the open subunits, for which the density is rather poor.
Computational Analyses
For structural comparison of Mad2 conformers, sets of atoms belong-
ing to the rigid core of the protein were first identified with ESCET
(Schneider, 2002). All available closed Mad2 molecules (3 copies of
the O-Mad2–C-Mad2 dimer and 4 copies of the Mad1–Mad2 com-
plexes, PDB entry 1GO4) are classified as a single conformationally
invariant fold, with no significant deviations in the main chain atom po-
sitions given the experimental uncertainties of the data. The same is
true for the 3 copies of open Mad2 in the O-Mad2–C-Mad2 assembly.
The largest structurally invariant region common to both open and
closed conformers identified by ESCET is represented by residues
16–45, 54–84, 97–102, 142–147 and 155–161. This set of atoms repre-
senting the main rigid core of the Mad2 fold was used for least-square
superposition of all conformers in O (Jones et al., 1991).
In Vitro Binding Assays
For GST-pulldown experiments in Figures 2–5, GST-Cdc20111–138 was
prepared as previously described (Sironi et al., 2002), and Mad2 mu-
tants purified as detailed above. To test the effects of point mutation
or deletion on the ability ofMad2 tobindCdc20, 1 mMGST-Cdc20111–138
pre-adsorbed on gluthatione (GSH) beads was incubated for 1 hr at
20C with 2 mM of the chosen Mad2 construct in a buffer containing
10 mMHEPES (pH 7.5), 0.1 MNaCl, 0.5 mMEDTA and 1mMDTT. Un-
bound Mad2 was washed away, and bound species resolved on SDS-
PAGE. To monitor whether mutations impaired O-Mad2–C-Mad2
dimerization, C-Mad2 was formed by incubating the desired Mad2
species with GST-Cdc20111–138 on GSH beads for 1 hr at 20C (first
addition). Then 2 mM of a second Mad2 moiety acting as an open con-
former (Mad2DC) in the dimer assembly was added (second addition),
and the incubation further protracted for 1 hr. After two washing steps,
complexes immobilized on beads were analyzed by SDS-PAGE.
Supplemental Data
Supplemental Data include four figures, one table, and Supplemental
References and can be found with this article online at http://www.
cell.com/cgi/content/full/131/4/730/DC1/.
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